{
    "id": "602498cb1cb411341a00009e",
    "question": "Is Olaparib effective for prostate cancer?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To determine whether Olaparib is effective for prostate cancer, we need to consider its primary indication and mechanism of action. Olaparib is a PARP inhibitor, which is primarily used in the treatment of ovarian cancer, breast cancer, and BRCA-mutated tumors. However, prostate cancer is a different type of cancer with distinct molecular mechanisms and treatment options. While there have been some studies exploring the use of PARP inhibitors in prostate cancer, the evidence is still limited and inconclusive. As of my knowledge cutoff, there is no strong evidence to support the use of Olaparib as a standard treatment for prostate cancer. In fact, Olaparib has been shown to be ineffective in clinical trials for prostate cancer. Therefore, the correct answer is B. no.\", \"answer_choice\": \"B\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 16.69071626663208
}